The prognostic significance of STAT3 in invasive breast cancer: analysis of protein and mRNA expressions in large cohorts

[1]  Hong Wang,et al.  Prognostic significance of STAT3/phosphorylated-STAT3 in tumor: a meta-analysis of literatures. , 2015, International journal of clinical and experimental medicine.

[2]  J. Cai,et al.  Prognostic Role of Phospho-STAT3 in Patients with Cancers of the Digestive System: A Systematic Review and Meta-Analysis , 2015, PloS one.

[3]  I. Ellis,et al.  Markers of progression in early-stage invasive breast cancer: a predictive immunohistochemical panel algorithm for distant recurrence risk stratification , 2015, Breast Cancer Research and Treatment.

[4]  X. Zhong,et al.  Dual high expression of STAT3 and cyclinD1 is associated with poor prognosis after curative resection of esophageal squamous cell carcinoma. , 2014, International journal of clinical and experimental pathology.

[5]  K. Shen,et al.  41PTHE PROGNOSIS OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 EXPRESSION ON BREAST CANCER SURVIVAL: A META-ANALYSIS AND RETROSPECTIVE STUDY , 2014 .

[6]  N. Sosonkina,et al.  The Role of STAT3 in Thyroid Cancer , 2014, Cancers.

[7]  L. Staudt,et al.  Activation of the STAT3 signaling pathway is associated with poor survival in diffuse large B-cell lymphoma treated with R-CHOP. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[8]  R. Moriggl,et al.  Both STAT1 and STAT3 are favourable prognostic determinants in colorectal carcinoma , 2013, British Journal of Cancer.

[9]  Q. Lv,et al.  STAT3, a Poor Survival Predicator, Is Associated with Lymph Node Metastasis from Breast Cancer , 2013, Journal of breast cancer.

[10]  E. Galun,et al.  Tumor STAT3 tyrosine phosphorylation status, as a predictor of benefit from adjuvant chemotherapy for breast cancer , 2013, Breast Cancer Research and Treatment.

[11]  Carlos Caldas,et al.  TOMM34 expression in early invasive breast cancer: a biomarker associated with poor outcome , 2012, Breast Cancer Research and Treatment.

[12]  F. Markowetz,et al.  The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups , 2012, Nature.

[13]  E. Galun,et al.  Tissue microarray-based study of patients with lymph node-positive breast cancer shows tyrosine phosphorylation of signal transducer and activator of transcription 3 (tyrosine705-STAT3) is a marker of good prognosis , 2012, Clinical and Translational Oncology.

[14]  Ying-chao Wang,et al.  Constitutive activation of STAT3 is predictive of poor prognosis in human gastric cancer , 2012, Journal of Molecular Medicine.

[15]  M. Campone,et al.  bc-GenExMiner: an easy-to-use online platform for gene prognostic analyses in breast cancer , 2012, Breast Cancer Research and Treatment.

[16]  A. Costa-Pereira,et al.  Signal transducers and activators of transcription-from cytokine signalling to cancer biology. , 2011, Biochimica et biophysica acta.

[17]  J. Grandis,et al.  STAT3 signaling: anticancer strategies and challenges. , 2011, Molecular interventions.

[18]  U. Dafni,et al.  Nuclear Localization of Signal Transducer and Activator of Transcription 3 in Head and Neck Squamous Cell Carcinoma Is Associated with a Better Prognosis , 2010, Clinical Cancer Research.

[19]  B. Aggarwal,et al.  Signal Transducer and Activator of Transcription‐3, Inflammation, and Cancer , 2009, Annals of the New York Academy of Sciences.

[20]  I. Ellis,et al.  Triple-Negative Breast Cancer: Distinguishing between Basal and Nonbasal Subtypes , 2009, Clinical Cancer Research.

[21]  C. Watson,et al.  The Stat family of transcription factors have diverse roles in mammary gland development. , 2008, Seminars in cell & developmental biology.

[22]  D. Louis,et al.  Deregulation of a STAT3–Interleukin 8 Signaling Pathway Promotes Human Glioblastoma Cell Proliferation and Invasiveness , 2008, The Journal of Neuroscience.

[23]  J. Siegfried,et al.  Immunohistochemical Analysis of Phosphotyrosine Signal Transducer and Activator of Transcription 3 and Epidermal Growth Factor Receptor Autocrine Signaling Pathways in Head and Neck Cancers and Metastatic Lymph Nodes , 2008, Clinical Cancer Research.

[24]  David E Levy,et al.  Identification of a PTEN-regulated STAT3 brain tumor suppressor pathway. , 2008, Genes & development.

[25]  R W Blamey,et al.  Survival of invasive breast cancer according to the Nottingham Prognostic Index in cases diagnosed in 1990-1999. , 2007, European journal of cancer.

[26]  Toshiyuki Nakayama,et al.  Activation of STAT3 is a marker of poor prognosis in human colorectal cancer. , 2006, Oncology reports.

[27]  E. Hurt,et al.  The role of IL-6 and STAT3 in inflammation and cancer. , 2005, European journal of cancer.

[28]  G. Ball,et al.  High‐throughput protein expression analysis using tissue microarray technology of a large well‐characterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses , 2005, International journal of cancer.

[29]  D. Levy,et al.  New and Old Functions of STAT3: A Pivitol Target for Individualized Treatment of Cancer , 2005, Cell cycle.

[30]  C. Clevenger.  Roles and regulation of stat family transcription factors in human breast cancer. , 2004, The American journal of pathology.

[31]  David A. Frank,et al.  Genome-wide analysis of STAT target genes: Elucidating the mechanism of STAT-mediated oncogenesis , 2004, Cancer biology & therapy.

[32]  David L Rimm,et al.  Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. , 2003, Clinical cancer research : an official journal of the American Association for Cancer Research.

[33]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[34]  McCarty Ks.  Histochemical approaches to steroid receptor analyses. , 1984 .

[35]  L. Kenner,et al.  The dark and the bright side of Stat3: proto-oncogene and tumor-suppressor. , 2009, Frontiers in bioscience.

[36]  C. Gardiner.  The role of STAT -3 in androgen-dependent prostate cancer , 2003 .